---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-100185"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2026-09-15T21:02:50+00:00"
generated_at: "2026-09-15T21:04:12.478497+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# HeartSciences Q1 FY27 net loss $3.2M; Fortitude merger closing in Q4 2026

## Summary
- Net loss $3.2M in FQ1 2027 (ended 7/31/26) vs $2.1M year-ago; operating loss $2.9M; no meaningful revenue.
- All-stock merger with Fortitude (Zcash mining) expected to close Q4 2026; Fortitude added 9,000 Z15 Pro miners (~7.5 Gsol/s) and a 12.5MW Nebraska facility.
- MyoVista Insights platform: first US commercial agreements, version 1.4, selected by major European reference center; patent portfolio >45 granted.
- Recorded $0.3M inventory reserve for MyoVista wavECG device; no further commercialization planned; FDA 510(k) still under review.
- Since period end: raised ~$1.0M from Fortitude, ~$1.2M net ATM, exchanged $200K note for shares; shareholders' deficit $2.0M.

## SEC filing metadata
- accession: 0001213900-26-100185
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2026-09-15T21:02:50+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000121390026100185/0001213900-26-100185-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000121390026100185/ea0305626-8k_heart.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-100185
- JSON: https://secwatch.observer/filing/0001213900-26-100185.json
- Plain text: https://secwatch.observer/filing/0001213900-26-100185.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.